# Ketorolac in Palatoplasty

> **NCT04771156** · PHASE4 · RECRUITING · sponsor: **The University of Texas Health Science Center, Houston** · enrollment: 74 (estimated)

## Conditions studied

- Cleft Lip and Palate

## Interventions

- **DRUG:** Ketorolac
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04771156
- **Lead sponsor:** The University of Texas Health Science Center, Houston
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-09-17
- **Primary completion:** 2027-03-01
- **Final completion:** 2027-04-01
- **Target enrollment:** 74 (ESTIMATED)
- **Last updated:** 2026-02-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04771156

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04771156, "Ketorolac in Palatoplasty". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04771156. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*